BioCardia, Inc. Q2 2023 Earnings Call Transcript - Insider Monkey
Slightly above 67% of BioCardia's investor base is looking to short. The analysis of current outlook of investing in BioCardia suggests that many traders are alarmed regarding BioCardia's prospects. BioCardia's investing sentiment can be driven by a variety of factors including economic data, BioCardia's earnings reports, geopolitical events, and overall market trends.
BioCardia |
BioCardia, Inc. Q2 2023 Earnings Call Transcript Insider Monkey
Read at news.google.com
 |
BioCardia Fundamental Analysis
We analyze BioCardia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioCardia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioCardia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
BioCardia is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Peers
Trending Equities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |